Back to search

Article

Highly efficient multiplex human T cell engineering without double-strand breaks using Cas9 base editors

2018-11-29

Abstract excerpt

Chimeric antigen receptor engineered T cell (CAR-T) immunotherapy has shown efficacy against a subset of hematological malignancies 1,2 , yet its autologous nature and ineffectiveness against epithelial and solid cancers limit widespread application. To overcome these limitations, targeted nucleases have been used to disrupt checkpoint inhibitors and genes involved in alloreactivity 3–6 . However, the production...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
cb5acde8-e61c-5c16-a289-4efcbf0b57e0
DOI
10.1101/482497
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Highly efficient multiplex human T cell engineering without double-strand breaks using Cas9 base editorsDOI 10.1101/482497
Select a neighboring publication to make it the new centre.